BridgeMD
Clonidine for postoperative pain management in patients undergoing spine surgery
EU CTIS ID: 2023-505969-80-00
What this study is testing
To examine analgesic efficacy and safety of intraoperatively administered intravenous clonidine in patients undergoing elective spine surgery on postoperative opioid consumption
- Therapeutic exploratory (Phase II)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Patients scheduled for degenerative spine surgery at Aarhus University Hospital will be included in the study.
You likely can't join if
- Age < 18 years
- Pregnancy and/or lactation
- Planned treatment with epidural analgesia, methadone, or infusion of ketamine in the perioperative period
- American Society of Anesthesiologists (ASA) physical status IV or V
- Allergy to clonidine
- Inability to provide informed consent
See the full eligibility criteria
- Patients scheduled for degenerative spine surgery at Aarhus University Hospital will be included in the study.
- Age < 18 years
- Pregnancy and/or lactation
- Planned treatment with epidural analgesia, methadone, or infusion of ketamine in the perioperative period
- American Society of Anesthesiologists (ASA) physical status IV or V
- Allergy to clonidine
- Inability to provide informed consent
- Known severe renal insufficiency (eGFR < 30)
- Known severe bradyarrhythmia
- Known severe ischemic heart disease
- Known severe congestive heart failure (Ejection Fraction < 30%)
- Known severe disseminated cancer disease
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.